ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2024

Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist.

Gerardo M Castillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.